Golden State Medical Supply Inc. Recalls NIACIN Extended-Release Tablets
This is a Class II recall. This product may cause temporary health problems or pose a slight threat of a serious nature.
Golden State Medical Supply Inc. Recalls NIACIN Extended-Release Tablets
Golden State Medical Supply Inc. · Class II — Moderate Risk

Product Description
NIACIN Extended-Release Tablets, USP, 1,000 mg, 90 tablets per bottle, Rx only, Manufactured by: Kremers Urban Pharmaceuticals, Inc., a subsidiary of Lannett Company, Inc., Seymour, IN 47274. Packaged by GSMS, Incorporated, Carmarillo, CA 93012. NDC: 51407-268-90
Reason for Recall
Failed Dissolution Specifications
FDA Classification
Class II — Moderate Risk
A situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
Distribution
Nationwide in the USA
Remedy
Consumers should stop using this product. Contact the recalling firm for further instructions regarding this product.
411 Press Analysis
A Class II FDA recall has been issued for a pharmaceutical product from Golden State Medical Supply Inc., initiated on October 20, 2025. Failed Dissolution Specifications. This recall covers 24,869 bottles, distributed nationwide. While not the highest severity, consumers should exercise caution and stop using the product until the recall is resolved.
Sources: FDA openFDA Enforcement Database
This recall appears in: Drug & Medical Product Contamination.